throbber
Appl Microbiol Biotechnol (1989) 31:486-489
`
`Enhanced biosurfactant production
`by a mutant Bacillus subtilis strain*
`
`Applied
`and MkroMotogy
`Biotechnology
`
`© Springer-Verlag 1989
`
`Catherine N. Mulligan1, Terry Y.-K. Chow2, and Bernard F. Gibbs3
`1 Biochemical Engineering Section, National Research Council of Canada, Biotechnology Research Institute, 6100 Royalmount
`Avenue, Montreal, Quebec H4P 2R2, Canada
`2 Genetic Engineering Section, National Research Council of Canada, Biotechnology Research Institute, 6100 Royalmount
`Avenue, Montreal, Quebec H4P 2R2, Canada
`3 Protein Engineering Section, National Research Council of Canada, Biotechnology Research Institute, 6100 Royalmount
`Avenue, Montreal, Quebec H4P 2R2, Canada
`
`Summary. Ultraviolet mutation of Bacillus subtilis
`ATCC 21332 yielded a stable mutant that pro­
`duced over three times more of the biosurfactant,
`surfactin, than the parent strain. By protoplast
`fusing the mutant (Suf-1) with the marker strain,
`B. subtilis BGSC strain IA28, the mutation was lo­
`cated between argCA and hisAi on the genetic
`map.
`
`Introduction
`
`Biosurfactants are produced as metabolic prod­
`ucts or membrane components. These compounds
`are lipopeptides, glycolipids, lipopolysaccharides,
`neutral lipids and fatty acids or phospholipids
`(Cooper 1986; Cooper and Zajic 1980; Margaritis
`et al. 1979; Rosenberg 1982; Zajic and Steffens
`1984). Surfactants are important as they are used
`in many multiphase processes (Layman 1985).
`Biosurfactants are biodegradable and potentially
`less toxic than the synthetic compounds currently
`used (Cooper and Zajic 1980). They can also be
`produced from a variety of substrates.
`Surfactin, produced by Bacillus subtilis ATCC
`21332 is one of the most effective biosurfactants
`known. It reduces the surface tension of water
`from 72 to 27 mN/m at a concentration as low as
`0.005% (Arima et al. 1968). This lipopeptide con­
`tains seven amino acids bonded to the carboxyl
`and hydroxyl groups of the 14-carbon acid (Ka-
`kinuma et al. 1969). It inhibits clot formation,
`lyses erythrocytes (Arima et al. 1968; Bernheimer
`and Avigad 1970), lyses bacterial spheroplasts
`and protoplasts and inhibits cyclic 3',5'-mono-
`
`* NRCC 30549
`Offprint requests to: B. F. Gibbs
`
`phosphate diesterase (Hosono and Suzuki 1983).
`It is produced from glucose instead of hydrocar­
`bons as is the case of most biosurfactants (Cooper
`et al. 1979).
`To increase commercial interest, yields of sur­
`factin must be improved. Until now the only
`methods which have been utilized to enhance pro­
`duction are strain selection of the manipulation of
`environmental or nutritional factors (Cooper et al.
`1981; Guerra-Santos et al. 1986). These methods,
`however, have their limitations as the levels of in­
`crease are marginal. Other approaches are there­
`fore necessary. Our research has concentrated on
`the isolation of mutants which overproduce sur­
`factin.
`
`Materials and methods
`
`Ultraviolet mutagenesis. The B. subtilis prototroph strain
`ATCC 21332 was grown to logarithmic phase and then ap­
`proximately 3000 cells were plated on nutrient agar plates. The
`cells were then UV radiated for 35 s with short wave in a Chro-
`mato-Vue Cabinet Model CC-60 (UVP, San Gabriel, Calif,
`USA). This dosage of UV light had been previously deter­
`mined to give 10%-20% survival of the colonies. The UV-irra-
`diated cells were incubated at 37° C in the dark until colonies
`were visible.
`
`Screening method for enhanced biosurfactant production. The B.
`subtilis mutants from UV mutagenesis were replica plated or
`individually spotted on to rich nutrient agar medium plates
`containing 5% sheep blood cells, 4% glucose, 0.1% nutrient
`broth, 0.1% yeast extract and mineral salts (Cooper et al.
`1981). The cells were incubated at 37° C and the haemolytic
`zone surrounding the colonies was scored visually. The degree
`of lysis of red blood cells has been shown to be related to the
`level of surfactin production by B. subtilis (Mulligan et al.
`1984).
`
`Surfactin production in liquid media. From a sheep blood agar
`plate, B. subtilis was inoculated into 4% glucose and mineral
`salts medium, supplemented with 3.2 x 10~4 M FeS04 (100/
`500 ml flasks) (Cooper et al. 1981). After 3 days growth, 10 ml
`
`PETITIONERS
`
`EXHIBIT NO. 1028 Page 1 of 4
`
`

`

`C. N. Mulligan et al.: Enhanced surfactin production by a B. subtilis mutant
`
`487
`
`culture was transferred to another flask. After 6 h growth,
`100 ml of this medium was used as an inoculum for a 3.7-1
`CHEMAP fermentor (Volketswil, Switzerland).
`The continuously stirred tank fermentor was operated un­
`der the following conditions: a 2.0-1 working volume, a tem­
`perature of 37° C, a 5.0 l/min aeration rate and pH control at
`6.7. The surfactin was removed continuously in the foam into
`a flask on the air exhaust line (Cooper et al. 1981).
`Growth was monitored by measuring the optical density
`(OD) of the fermentor broth at 600 nm; samples above OD 1.0
`AUFS were diluted appropriately. For both strains, on OD of
`1.0 AUFS represents 0.21 g/1 biomass. Insignificant amounts
`of cells were found in the foam. Surface tension of the broth
`was measured by a Fisher Surface Tensiomat Model 21 (Mon­
`treal, Canada), a du Nouy tensiometer (Cooper et al. 1979).
`
`Chemical isolation of surfactin. Using concentrated hydro­
`chloric acid, the pH of the collapsed foam after cell removal
`was adjusted to 2±0.5 (Cooper et al. 1981). This precipitated
`the proteins and lipids. After decanting the supernatant, the
`residue was resuspended in dichloromethane in a separatory
`funnel and shaken vigorously. Surfactin was recovered in the
`organic (top) layer. Two more extractions were performed and
`the organic layers were pooled and evaporated. The residue
`was redissolved in slightly basic water (pH 8.0) and filtered
`through Whatman no. 1 paper to remove undissolved impuri­
`ties. The filtrate was again adjusted to pH 2 ±0.5 and ex­
`tracted with dichloromethane three times and evaporated as
`described above.
`
`Surfactin assay. The biosurfactant yield of the collapsed foam
`was determined by both critical micelle concentration (CMC)
`and amino acid analysis. The CMC values were determined by
`measuring the surface tension at various dilutions (Cooper et
`al. 1979). The logarithm of the dilution was plotted as a func-
`
`tion of surface tension. The CMC is the point of abrupt sur­
`face tension increase. The surfactant concentration is thus a
`function of the CMC.
`An aliquot of the collapsed foam was trichloracetic acid-
`treated to precipitate peptides and proteins. The supernatant
`was assayed to determine the free amino acids in the medium.
`The residue (pellet) was redissolved in 25% trifluoroacetic acid
`and an aliquot was removed, dried and acid hydrolysed for
`2.5 h at at 150oC in a Waters PICO-TAG Amino Acid Analy­
`sis System (Mass, USA). This enabled us to determine the am­
`ino acids in the peptide portion of surfactin. According to the
`molecular formula (Kakinuma et al. 1969), the peptidyl por­
`tion of surfactin is 76.5% by weight of the intact molecule. All
`amino acid analyses were done on a Beckman System 6300
`High Performance Analyser equipped with a Beckman Model
`7000 Data Station (Palo Alto, Calif, USA).
`
`Mass spectrometry. Mass spectra were obtained in the positive
`ion mode on a VG Analytical ZAB-HS double focussing mass
`spectrometer (Manchester, UK). The accelerating voltage was
`10 kV and the fast xenon atom beam was operated with an
`emission current of 1 mA at 8 kV. Mass spectra were recorded
`with an integrated data acquisition sytem and calibration was
`performed with Csl. Spectra for samples are an average of ten
`scans.
`
`Media for protoplast fusion. For the isolation of auxotrophs,
`transformants or transductants, Spizizen minimal medium
`(SMM) (Spizizen 1958) was used. For protoplast regeneration,
`HCP-1.5 medium containing glucose (5 g/1), casamino acids
`(5 g/1), K2HPO4 (3.5 g/1), KH2PO4 (1.5 g/1), L-tryptophan
`(0.1 g/1), polyvinylpyrrolidone (PVP) (mean molecular weight
`700000, 15 g/1), MgCla (1.9 g/1) and 25% (v/v) 2M sodium
`succinate (pH 7.3); HCP-1.5 agar contained the same compo­
`nents supplemented with agar (8 g/1). The HCP-3 medium was
`the same as HCP-1.5 with the exception of 30 g/1 PVP.
`
`.4
`
`"8
`
`Fig. 1. Haemolysis by mutant and other strains on blood agar. Parent strain B. subtilis ATCC 21332 (A), UV radiated colonies (B
`and D) and the mutant Suf-1 (C). Growth was for 2 days at 37° C
`
`PETITIONERS
`
`EXHIBIT NO. 1028 Page 2 of 4
`
`

`

`488
`
`C. N. Mulligan et al.: Enhanced surfactin production by a B. subtilis mutant
`
`Protoplast fusion. Protoplast fusion between the enhanced pro­
`duction mutant and BGSC strain 1A28 (argCA, AisAl and
`trpC2) and regeneration was according to Akamatsu and Se-
`kiguchi (1987). Cells were placed in SMM medium with
`250 ug/ml lysozyme and incubated at 42° C for 45 min. The
`protoplasts were suspended in HCP-3 medium (30° C) for 3 h
`without shaking. The protoplast suspensions from the two
`strains were mixed and then centrifuged (4000 g, 10 min). The
`pellet was vortexed in SMM medium and 40% polyethylene
`glycol 4000 (average molecular weight 3000) was then added.
`The protoplast suspension was left to stand for one min fol­
`lowed by dilution with HCP-1.5 medium. The protoplasts were
`regenerated by placing 0.1 ml suspension on the surface of
`HCP-1.5 agar medium. Colonies were streaked on nutrient
`agar and single colonies were analysed for unselected mark-
`ers.
`
`Results and discussion
`
`Selection of a mutant
`
`To enhance biosurfactant production, mutation
`was chosen since any change in the regulatory
`system of biosurfactant synthesis and secretion
`could result in an altered level of production.
`After ultraviolet mutagenesis, approximately 1000
`colonies were examined for enhanced haemolytic
`activity on sheep blood agar plates. One mutant,
`Suf-1, (C) produced a significantly larger haemo­
`lytic zone than the parent strain (Fig. 1). This mu­
`tant was not an auxotroph as it was able to grow
`in minimal medium. Without radiation, no colo­
`nies out of 1000 produced significantly higher lev­
`els of surfactant.
`
`Biosurfactant production
`
`To compare biosurfactant production by the mu­
`tant and parent strains, both were grown similarly
`
`Table 1. Enhanced production of biosurfactant by Bacillus
`subtilis Suf-1
`
`Strain
`
`Growth after 40 h
`(optical density
`at 600 nm)
`
`ATCC 21332
`Suf-1
`
`8.2
`8.3
`
`Surfactant
`yield (mg)a
`
`328
`1124
`
`a Surfactant collected in the foam was determined by amino
`acid analysis and represents the amount produced in the fer-
`mentor
`
`in a fermentor. Suf-1 produced 3.4 times more
`biosurfactant than the parent strain over the same
`time period into the foam (Table 1). In both cases
`surfactin was totally (> 99%) transferred from the
`fermentor medium into the foam. The growth of
`the two strains was approximately equal. Several
`single isolates of the same colony Suf-1 after
`many generations produced the same enhanced
`levels of surfactant in liquid medium. The Suf-1
`mutation, therefore, was stable and did not revert
`in subculturing.
`
`Biosurfactant characterization
`
`The purified surfactant from the mutant and wild-
`type had similar amino acid profiles, which
`agreed with the compositon of surfactin (Kakin-
`uma et al. 1969). Impure surfactant produced dif­
`ferent peptidyl profiles. Furthermore, confirma­
`tion of the structure of the biosurfactants was ob­
`tained by FAB-MS (fast atom bombardment mass
`spectrometry). Based on the surfactin molecular
`formula (C53H93N7O13), the protonated molecular
`weight is 1036.69. The spectra of the compounds
`
`100 -1
`
`1023
`
`1036
`
`1061
`
`1047
`
`1009
`
`80 -
`
`60 -
`
`40 -
`
`20 -
`
`1037
`
`1008
`
`1023
`
`1062
`
`1046
`
`' b
`
`1077
`
`a
`
`1078
`
`1090
`
`1055
`
`1091
`
`1
`
`0
`1000
`
`1020
`
`1040
`
`1080
`
`1100 1000
`
`1020
`
`1060
`
`1080
`
`1100
`
`1060
`1040
`Mass
`Mass
`Fig. 2. Mass spectra of the purified biosurfactants isolated from the parent organism (A) and the hyperproductive mutant (B)
`
`PETITIONERS
`
`EXHIBIT NO. 1028 Page 3 of 4
`
`

`

`C. N. Mulligan et al.: Enhanced surfactin production by a B. subtilis mutant
`
`489
`
`produced by the parent strain (Fig. 2A) and the
`mutant strain (Fig. 2B) were quite similar with
`molecular ions at 1036 and 1037, respectively.
`Their fragmentation pattern was also in harmony,
`with minor differences in intensities.
`The screening method (Mulligan et al. 1984)
`for enhanced surfactin production was confirmed
`as these isolated compounds, solubilized
`in
`slightly basic water (pH 8.0), promoted haemoly­
`sis of the blood agar plates.
`
`the wild-type. The mutation for increased produc­
`tion was mapped between argCA and hisA\ on the
`B. subtilis chromosome, as determined by proto­
`plast fusion. This information provides a target
`site for future genetic manipulation.
`Acknowledgements. The authors would like to thank Dr. Orval
`A. Mamer of the McGill University Biomedical Mass Spec­
`trometry Unit (Montreal, Canada) and Dr. Marie-Renee de
`Roubin of the Biotechnology Research Institute for their ex­
`pert technical assistance.
`
`Location of the suf-1 mutation
`Protoplast fusion was performed to locate the
`area on the chromosome of the mutation respon­
`sible for enhanced surfactin production. The B.
`subtilis BGSC strain IA28 was chosen for the
`three markers (argCA, hisM and trpCl), evenly
`spaced on the genetic map (Piggot and Hoch
`1985). The marker strain produced very small
`amounts of biosurfactant on blood agar, no dif­
`ferent from strain ATCC 21332. The linkage of
`the Suf-1 phenotype and the marker gene should
`give the approximate location of the suf-l muta­
`tion with respect to the markers on the B. subtilis
`chromosome.
`Loss of enhanced surfactant production by
`Suf-1 during fusion occurred upon specific re­
`combinations of the mutated and marked areas
`(Table 2). This evidence suggested that the suf-\
`mutation corresponded with the area between
`argCA and hisM and furthest from trpCl. A sin­
`gle mutation in a specific region rather than mul­
`tiple mutations throughout the genome must be
`responsible for increased surfactin production.
`In summary, we increased biosurfactant pro­
`duction greater than threefold with B. subtilis Suf-
`1 by ultraviolet mutagenesis. Surfactin produced
`by this strain was identical to that produced by
`
`Table 2. Distribution of unselected marker classes among re­
`combinants obtained by protoplast fusion between B. subtilis
`IA28 (ArgCA HisM TrpCl) and Suf-1
`
`Number of colonies
`carrying indicated
`unselected markers
`
`Trp
`
`+
`+
`+
`
`His
`
`+
`+
`
`Arg
`
`+
`
`Numbers
`
`% Frequency
`of Suf-1
`
`153
`88
`32
`
`80 (121/153)"
`49 (43/88)
`0 (0/32)
`
`a In parentheses are the numbers of Suf-1 recombinants per
`number of recombinants examined in each class. Presence of
`Suf-1 was indicated by haemolysis of blood agar plates
`
`References
`
`Akamatsu T, Sekiguchi J (1987) Genetic mapping by means of
`protoplast fusion in Bacillus subtilis. Mol Gen Genet
`208:254-262
`Arima K, Kakinuma A, Tamura G (1968) A crystalline peptide
`lipid surfactant produced by Bacillus subtilis: isolation,
`characterization and its inhibition of fibrin clot formation.
`Biochem Biophys Res Commun 31:488-494
`Bernheimer AW, Avigad LS (1970) Nature and properties of a
`cytolic agent produced by Bacillus subtilis. J Gen Microbiol
`61:361-369
`Cooper DG (1986) Biosurfactants. Mirobiol Sci 3:145-149
`Cooper DG, Zajic JE (1980) Surface active compounds from
`microorganisms. Adv Appl Microbiol 26:229-253
`Cooper DG, Zajic JE, Gerson DF (1979) Production of sur­
`face active lipids by Corynebacterium lepus. Appl Environ
`Microbiol 37:4-10
`Cooper DG, MacDonald CR, Duff SIB, Kosaric N (1981) En­
`hanced production of surfactin from Bacillus subtilis by
`continuous product removal and metal cation additions.
`Appl Environ Microbiol 42:408-412
`Guerra-Santos LH, Kappeli O, Fiechter A (1986) Dependence
`of Pseudomonas aeruginosa continuous culture biosurfac­
`tant production on nutritional and environmental factors.
`Appl Microbiol Biotechnol 24:443-448
`Hosono K, Suzuki H (1983) Acylpeptides, the inhibitors of
`cyclic adenosine 3'-5' monophosphate phosphodiesterase.
`III. Inhibitors of cyclic AMP phosphodiesterase. J Antibiot
`36:679-683
`Kakinuma A, Oachida A, Shima T, Sugino H, Isono M, Ta­
`mura G, Arima K (1969) Confirmation of the structure of
`surfactin by mass spectroscopy. Agric Biol Chem 33:1669-
`1671
`Layman PL (1985) Industrial surfactants set for strong growth.
`Chem Eng News 63:23-48
`Margaritis A, Zajic JE, Gerson DF (1979) Production and sur­
`face properties of microbial surfactants. Biotechnol Bioeng
`21:1151-1161
`Mulligan CN, Cooper DG, Neufeld RJ (1984) Selection of mi­
`crobes producing biosurfactants on media without hydro­
`carbons. J Ferment Technol 62:311-314
`Piggot PJ, Hoch JA (1985) Revised genetic linkage map of Ba­
`cillus subtilis. Microbiol Rev 49:158-179
`Rosenberg E (1982) Microbial surfactants. CRC Crit Rev Bio-
`technol 1:109-32
`Spizizen J (1958) Transformation of biochemically deficient
`strains of Bacillus subtilis by deoxyribonucleate. Proc Natl
`Acad Sci USA 44:395-405
`Zajic JE, Steffens W (1984) Biosurfactants. CRC Crit Rev Bio­
`technol 1:87-107
`
`Received 15 December 1988/Accepted 9 May 1989
`
`PETITIONERS
`
`EXHIBIT NO. 1028 Page 4 of 4
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket